Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress

The 2026 American Transplant Congress, jointly organized by the American Society of Transplant Surgeons and the American Society of Transplantation, highlighted the expanding role of machine perfusion (MP) in broadening the donor pool across liver, kidney, lung, heart, and vascularized composite allograft transplantation. Of 106 relevant abstracts identified, 39 with the greatest clinical and translational relevance were selected for discussion. Across organ systems, normothermic and hypothermic MP facilitated utilization of higher-risk grafts, including donation-after-circulatory-death, steatotic, and extended-criteria organs, with early outcomes comparable or superior to static cold storage. Normothermic regional perfusion emerged as a complementary preconditioning strategy, particularly in reducing biliary complications after liver transplantation and delayed graft function after kidney transplantation. Novel biomarkers, including perfusate flavin mononucleotide, and integrated biochemical, physiologic, and histologic panels showed promise for real-time graft viability assessment. Emerging approaches, including 7-day liver preservation, ischemia-free liver transplantation, gaseous cardiac perfusion, and ex situ modeling of T-cell-mediated rejection, further suggest that MP is evolving into a therapeutic and investigative platform. Important limitations include variable benefits across recipient risk profiles, cardiac size-matching constraints, and disparities in access to normothermic liver perfusion. Multicenter validation, equitable access, and organ- and risk-specific strategies will be essential to realize the full potential of MP in transplantation.

Authors

Institutions

Publication Details

Journal
Surgeries
Published
2026-11-17
DOI
https://doi.org/10.3390/surgeries7040135
Primary Topic
Organ Transplantation Techniques and Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress

Kathryn White, Maheswaran Pitchaimuthu, Harshini Maheswaran, Hope Neal
2 links
Surgeries
Organ Transplantation Techniques and Outcomes
article

Machine Perfusion Across Solid Organ and Vascularized Composite Allograft Transplantation: Updates from the 2026 American Transplant Congress

Kathryn White, Maheswaran Pitchaimuthu, Harshini Maheswaran, Hope Neal
article en

Abstract

The 2026 American Transplant Congress, jointly organized by the American Society of Transplant Surgeons and the American Society of Transplantation, highlighted the expanding role of machine perfusion (MP) in broadening the donor pool across liver, kidney, lung, heart, and vascularized composite allograft transplantation. Of 106 relevant abstracts identified, 39 with the greatest clinical and translational relevance were selected for discussion. Across organ systems, normothermic and hypothermic MP facilitated utilization of higher-risk grafts, including donation-after-circulatory-death, steatotic, and extended-criteria organs, with early outcomes comparable or superior to static cold storage. Normothermic regional perfusion emerged as a complementary preconditioning strategy, particularly in reducing biliary complications after liver transplantation and delayed graft function after kidney transplantation. Novel biomarkers, including perfusate flavin mononucleotide, and integrated biochemical, physiologic, and histologic panels showed promise for real-time graft viability assessment. Emerging approaches, including 7-day liver preservation, ischemia-free liver transplantation, gaseous cardiac perfusion, and ex situ modeling of T-cell-mediated rejection, further suggest that MP is evolving into a therapeutic and investigative platform. Important limitations include variable benefits across recipient risk profiles, cardiac size-matching constraints, and disparities in access to normothermic liver perfusion. Multicenter validation, equitable access, and organ- and risk-specific strategies will be essential to realize the full potential of MP in transplantation.

SurgeriesVol. 7(4)
University of Oklahoma Medical Center (US), University of Oklahoma (US)
Good health and well-being
Organ Transplantation Techniques and Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon